The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPATH.L Regulatory News (PATH)

  • There is currently no data for PATH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of Prospectus, Notice of GM, Fundraise

14 Mar 2022 13:09

RNS Number : 7025E
Path Investments plc
14 March 2022
 

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, CANADA, AUSTRALIA, THE REPUBLIC OF SOUTH AFRICA, JAPAN OR ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA ("EEA") (OTHER THAN ANY MEMBER STATE OF THE EEA WHERE SECURITIES MAY BE LAWFULLY MARKETED) OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE OR FORM PART OF ANY OFFER TO ISSUE OR SELL, OR ANY SOLICITATION OF ANY OFFER TO SUBSCRIBE OR PURCHASE, ANY INVESTMENTS IN ANY JURISDICTION.

 

This announcement is an advertisement for the purposes of the Prospectus Regulation Rules of the UK Financial Conduct Authority ("FCA") and is not a prospectus. This announcement does not constitute or form part of, and should not be construed as, an offer for sale or subscription of, or solicitation of any offer to subscribe for or to acquire, any ordinary shares in Path Investments plc in any jurisdiction, including in or into the United States, Canada, Australia, the Republic of South Africa or Japan. Investors should not subscribe for or purchase any ordinary shares referred to in this announcement except on the basis of information in the prospectus (the "Prospectus") in its final form, published by Path Investments plc in connection with the proposed acquisition of DG Innovate Ltd and the admission of its enlarged ordinary share capital to the Standard Listing segment of London Stock Exchange plc's Main Market for listed securities.

 

 

14 March 2022

 

Path Investments plc

("Path" or the "Company")

Further re the Acquisition of DG Innovate

 

Publication of Prospectus

£4.6 million Fundraise

Proposed Waiver of Rule 9 of the Takeover Code

Proposed Change of Name to DG Innovate plc

Proposed Issue of Warrantsand

Notice of General Meeting

 

 

Path Investments plc (TIDM: PATH), is pleased to announce the publication of a prospectus (the "Prospectus") in relation to the Company's proposed acquisition of DG Innovate Ltd ("DG Innovate") which contains a notice of General Meeting. This follows the Company's announcements on 13 August 2021, 31 December 2021 and 1 February 2022 that it had entered into a conditional sale and purchase agreement ("SPA") to acquire the entire issued share capital of DG Innovate (the "Acquisition").

Highlights

 

· As previously announced the Company has conditionally agreed to acquire DG Innovate. The initial consideration of £32.4 million is to be satisfied by the issue to the DG Innovate Shareholders of 5,397,451,305 Path Ordinary Shares ("Initial Consideration Shares") at a deemed issue price of 0.6 pence per Ordinary Share. Further conditional deferred consideration of up to £5.4 million, to be satisfied by the issue of up to 895,610,844 Path Shares ("Deferred Consideration Shares") on the first anniversary of completion, will become payable should DG Innovate sign one or more supply agreements for the provision of their motor technology with certain defined customers prior to this date with a combined potential value of £5 million or more.

 

· The Acquisition is conditional, inter alia, on shareholder approval of the proposals and upon the Company's Ordinary Shares being re-admitted to the Standard Listing segment of the Official List and trading on the Main Market of the London Stock Exchange ("Admission"). A general meeting to obtain Path shareholder approval is to be held at 2:00 p.m. on 1 April 2022 (the "General Meeting").

 

· DG Innovate is an advanced research and development company pioneering sustainable and environmentally considerate improvements to electric mobility and storage, using abundant materials and the best engineering and scientific practices. DG Innovate is currently developing its products alongside a number of major manufacturers across the transportation and energy sectors, research institutions and the UK Government, and has filed 18 patents worldwide. DG Innovate's current research and development activities are broadly split into two areas, focusing on novel electric motor technologies and energy storage solutions. Its two main products are:

 

o Enhanced Drive Technology (EDT) - High efficiency, lightweight, cost-effective electric motors and electronics; and

o Enhanced Battery Technology (EBT) - Sodium-ion batteries offering a sustainable energy storage solution at similar/greater energy density to incumbent technologies at a lower cost, increased safety with lower environmental footprint.

 

· The Company has conditionally raised £2,550,000 through the issue of 510,000,000 Subscription Shares at 0.5p per Ordinary Share. Further, the Company has received irrevocable exercise notices, conditional on Admission, in respect of 830,800,000 Warrants (0.25p) raising an additional £2,077,000.

 

· It is proposed that the Company's name be changed to DG Innovate plc.

 

· The proposed appointment of Martin Boughtwood as CTO and Patrick Symonds, Sir Stephen Dalton, Andrew Boughtwood and Trevor Gabriel as non-executive directors of the Company and the proposed retirement of Brent Fitzpatrick.

 

· If the proposals are approved at the General Meeting, it is expected that Admission and dealings in the Company's Ordinary Shares will commence on the London Stock Exchange on or around 8.00 a.m. on 8 April 2022.

 

Commenting, Christopher Theis, CEO of Path, said:

 

"We are delighted to have completed the required prospectus in relation to our proposed acquisition of DG Innovate and to now be seeking formal shareholder approval for the Acquisition. We believe that the acquisition of DG Innovate presents a compelling value opportunity for the Company with DG Innovate having a strong technology and IP portfolio, targeted at current market technology's shortcomings, coupled with significant commercial relationships, high calibre technical staff and near-term commercialisation opportunities.

 

"We have assembled a strong board to guide the new DG Innovate plc and we look forward to shareholders having the opportunity to formally approve the proposals at the General Meeting later this month. I would also like to take this opportunity to thank Brent Fitzpatrick, who is proposing to step down as Chairman at Admission, for his wise counsel, support and dedication over a long period as we sought to conclude an appropriate transaction that we believe can deliver significant value for shareholders."

 

Capitalised terms in this announcement shall have the same meaning as in the Prospectus.

For further information please contact:

Path Investments plc

C/O IFC

Christopher Theis

Jack Allardyce

 

 

 

IFC Advisory (Financial PR & IR)

020 3934 6630

Tim Metcalfe

Zach Cohen

 

 

 

Grant Thornton UK LLP (Financial Adviser)

Samantha Harrison

Harrison Clarke

Daphne Zhang

020 7383 5100

 

 

 

ETX Capital (Broker)

020 7392 1400

Tom Curran

Thomas Smith

 

 

 

 

Background

 

The Company announced on 12 August 2021 that it had conditionally agreed to acquire the entire issued share capital of DG Innovate. The initial consideration, is £32,384,707, to be satisfied by the issue to the DG Innovate Shareholders of the Initial Consideration Shares at a deemed issue price of 0.6 pence per Ordinary Share.

 

The terms of the SPA were varied on 1 February 2022 and it was agreed that further consideration of £5,373,665 would be payable to the Sellers, to be satisfied by the issue of the Deferred Consideration Shares, subject to the achievement by DG Innovate of the Deferred Consideration Targets during the first year following Completion. The Deferred Consideration Targets require the obtention within 12 months following completion by the DG Innovate Group of one or more profit generating supply contract(s) with a combined value of £5,000,000 or more, or (as may be agreed in writing between the Company and the Sellers' Representative) with a combined potential value of £5,000,000 or more.

 

The Acquisition constitutes a Reverse Takeover under the Listing Rules as it will result in a fundamental change in the business and management of the Company. Trading in the Existing Ordinary Shares was suspended with effect from 12 August 2021 on announcement of the potential reverse takeover and pending the publication of a prospectus and completion of the Acquisition. The Acquisition is conditional, inter alia, upon Admission and the approval by Existing Shareholders of certain Resolutions at the Company's General Meeting to be held on 1 April 2022.

 

The Prospectus explains the background to and reasons for the Acquisition, how it aligns with the Company's strategy and why the Existing Directors believe that the Acquisition and the Subscription are in the best interests of the Company and its Existing Shareholders.

 

The proposals are conditional, inter alia, on the passing of the Resolutions by Shareholders at the General Meeting and Admission. If the proposals are approved, it is expected that Admission will become effective and dealings in the Path Ordinary Shares will commence on the London Stock Exchange on or around 8.00 a.m. on 8 April 2022.

 

Background on DG Innovate

 

DG Innovate (formerly Deregallera Holdings Ltd) is an advanced research and development company pioneering sustainable and environmentally considerate improvements to electric mobility and storage, using abundant materials and the best engineering and scientific practices. DG Innovate is currently developing its products alongside a number of major manufacturers across the transportation and energy sectors, research institutions and the UK Government and has filed 18 patents worldwide.

 

DG Innovate's current research and development activities are broadly split into two areas, focusing on novel electric motor technologies and energy storage solutions. Its two main products are:

 

Enhanced Drive Technology (EDT) - High efficiency, lightweight, cost-effective electric motors and electronics; and

Enhanced Battery Technology (EBT) - Sodium-ion batteries offering a sustainable energy storage solution at similar/greater energy density to incumbent technologies at a lower cost, increased safety with lower environmental footprint

 

DG Innovate was founded in 2009 by Martin Boughtwood with a vision of delivering sustainable and environmentally considerate improvements to electric mobility and storage, using abundant materials and the best engineering and scientific practices. Specifically, DG Innovate has sought to address the major problems facing both electric mobility and energy storage. For the former, the key barrier to market penetration to date has been the effective real-world range of electric vehicles. DG Innovate has therefore focused on developing electric drive systems which aim to deliver improved range over existing technology, based on the same battery capacity, by reducing losses and improving efficiency. DG Innovate has a long-standing working relationship with the UK Government and is also collaborating with a global Tier 1 supplier to the commercial vehicle market.

 

In its energy storage development, which commenced in 2013, DG Innovate has focused on developing anode active materials as a key enabling technology for sodium-ion batteries. DG Innovate is in collaboration or commercial contact with several companies throughout the supply chain with the view towards volume commercialisation in the medium term.

 

DG Innovate has developed a significant intellectual property portfolio since its foundation, including a novel electric motor and corresponding architecture and a suite of energy storage materials (including sodium-ion cells and supercapacitors). It has been granted 11 patents during this time, with a further seven pending and a number of drafts under consideration.

 

To date DG Innovate has received approximately £18.6 million in funding through a mixture of equity from private funders, debt, grants and research funding from the UK Government, the Welsh Development Agency and through highly competitive grant awards under the Innovate UK Faraday Challenge. Additionally, Path has provided secured loan facilities to DG Innovate of which £900,000 has been drawn. As at the Last Practicable Date DG Innovate has £150,000 remaining available under the facilities.

 

Fundraising and use of proceeds

 

The Company is undertaking a Subscription to raise £2,550,000 by the issue of 510,000,000 Subscription Shares at 0.5p per Ordinary Share. The Company has entered into subscription agreements with the Subscribers which are conditional, inter alia, upon completion of the Acquisition and Admission. Further, the Company has received irrevocable exercise notices, conditional on Admission, in respect of 830,800,000 Warrants (0.25p) raising an additional £2,077,000.

 

The aggregate fundraise of approximately £4,627,000 will be used by the Enlarged Group to fund research and development costs, working capital for the Enlarged Group, transaction costs associated with the Acquisition and Admission, and to repay loans from certain DGI shareholders.

 

Proposed Board on Admission

 

The Company's Existing Board consists of four Directors, Brent Fitzpatrick, Christopher Theis, John Allardyce and Nicholas Tulloch. It is proposed that Mr Fitzpatrick will step down from the Board at Admission and it is proposed that Martin Boughtwood, Patrick Symonds, Sir Stephen Dalton, Andrew Boughtwood and Trevor Gabriel be appointed. The Board would like to thank Mr Fitzpatrick for his considerable efforts in his time with the Company.

 

Further details on the Directors are set out in the Appendix below.

 

The Takeover Code

 

The Acquisition gives rise to certain considerations under the Takeover Code. Under Rule 9 of the Takeover Code ("Rule 9"), any person who acquires an interest in shares (as defined in the Takeover Code), whether by a series of transactions over a period of time or not, which (taken together with any interest in shares held or acquired by persons acting in concert (as defined in the Takeover Code) with him) in aggregate, carry 30 per cent. or more of the voting rights of a company which is subject to the Takeover Code, that person is normally required by the Panel to make a general offer, in cash, to all of the remaining shareholders to acquire their shares.

 

The Company has agreed with the Takeover Panel that certain of the shareholders of DG Innovate should be considered to be "acting in concert" for the purposes of the Takeover Code (as such term is defined in the Takeover Code). At Admission, following completion of the Acquisition and Subscription and conditional on the Rule 9 Waiver, the Concert Party will be interested in an aggregate of 4,468,274,325 Ordinary Shares representing approximately 50.5 per cent. of the Enlarged Share Capital. The members of the Concert Party and the interest of each member of the Concert Party in the Enlarged Share Capital are set out below in the appendix.

 

The Company has applied to the Panel for, and the Panel has agreed to, a waiver of the obligations under Rule 9 of the Takeover Code, subject to the passing of the Rule 9 Waiver Resolution by the Independent Shareholders on a poll at the General Meeting, to waive the obligation of the Concert Party, collectively and/or individually, to make a mandatory general offer under Rule 9 for the Ordinary Shares not already owned by it as would otherwise arise following the issue of the Consideration Shares and Concert Party Options.

 

Given that, following the issue of the Initial Consideration Shares the Concert Party will hold more than 50 per cent. of the voting share capital of the Company, any further acquisitions of the Company's shares by any member of the Concert Party, whether individually or collectively, would normally not trigger any obligation under Rule 9 of the Takeover Code to make a general mandatory offer to Shareholders to acquire the entire issued share capital of the Company. However, notwithstanding the waiver and Rule 9 Waiver resolution, individual members of the Concert Party would not be able to increase their percentage interest in the Ordinary Shares of the Company through, or between, a Rule 9 threshold without the consent of the Panel.

 

Following Admission, should the Deferred Consideration Shares be issued in full and the Concert Party exercise the options held by them (assuming no new shares are issued in the meantime), the Concert Party will hold in aggregate a maximum of 5,414,930,957 Ordinary Shares representing approximately 54.5 per cent. of the Partially Diluted Enlarged Share Capital. Should the Concert Party holding fall below 50 per cent. prior to the issue of Deferred Consideration Shares and/or the Concert Party Options being exercised, subject to approval of the Rule 9 Waiver, the Concert Party will not be required to make a mandatory general offer as a result of the acquisition of Ordinary Shares pursuant to either the exercise of the Concert Party Options or the issue of the Deferred Consideration Shares.

 

Change of Name

 

To support the strategy going forwards, the Company is also proposing to change its name to DG Innovate plc, subject to the passing of the proposals and Admission. At that time, the Company's stock ticker symbol will be changed to "DGI". The Company's website address will be changed to www.dgiplc.com.

 

Issue of Warrants

 

The Company has agreed, subject to Shareholder approval at the General Meeting, to allot a total of 670,400,000 Warrants (1p) on the basis that: (i) one Warrant (1p) will be issued to each Subscriber for every two Subscription Shares issued to each Subscriber, which will result in the issue of 255,000,000 Warrants (1p); and (ii) one Warrant (1p) will be issued to each holder of Warrants (0.25p) for every two Warrants (0.25p) exercised pursuant to the Warrant Exercise Notices, which will result in the issue of 415,400,000 Warrants (1p).

 

Availability of the Prospectus 

 

The Prospectus will be made available on the Company's website at: www.pathinvestmentsplc.com. An electronic copy of the Prospectus will also be submitted to the National Storage Mechanism and should be available shortly for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

Notice of General Meeting

 

A General Meeting of the Company will be held at the offices of Womble Bond Dickinson (UK) LLP, 4 More London Riverside, SE1 2AU on 1 April 2022 at 2:00 p.m.

 

The Notice of General Meeting and details of the matters to be considered at the meeting, which includes inter alia shareholder approval for the issue of shares in connection with the proposed acquisition of DG Innovate and the Subscription, is contained within the Prospectus.

 

In accordance with the requirements of the Panel, the Rule 9 Waiver Resolution will be taken on a poll of Independent Shareholders. Certain shareholders are not considered to be independent for the purposes of the Rule 9 Waiver and have undertaken to the Company that they will not vote on the Rule 9 Waiver Resolution in respect of in aggregate 355,300,000 Ordinary Shares. Consequently, only Independent Shareholders holding 1,674,163,802 Ordinary Shares, representing 82.5% of the existing share capital of the Company as at the date of this Document, will be entitled to vote on Rule 9 Waiver Resolution.

 

Total Voting Rights

 

The total number of Ordinary Shares with voting rights in the Company with effect from Admission is 8,842,715,107. The Company does not hold any shares in treasury and all of the ordinary shares have equal voting rights. This figure may be used by shareholders as the denominator for the calculations by which they determine if they are required to notify their interest in, or a change of their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Proposed Timetable of Key Events

 

The proposed timetable of key events is as follows:

 

Publication of Prospectus

14 March 2022

Latest time and date for receipt of Forms of Proxy for the General Meeting

2.00 p.m. on 30 March 2022

Time and date of General Meeting

2.00 p.m. on 1 April 2022

Result of the General Meeting announced through RIS

1 April 2022

Cancellation of trading of Ordinary Shares

8.00 a.m. on 8 April 2022

Completion of the Acquisition

8 April 2022

Re-Admission and commencement of dealings on the London Stock Exchange of the Enlarged Share Capital

8.00 a.m. on 8 April 2022

Delivery of New Ordinary Shares into CREST as soon as practicable after

8:00 a.m. on 8 April 2022

New Ordinary Share certificates dispatched

15 April 2022

 

Admission Statistics

 

Number of Existing Ordinary Shares at the date of this announcement

2,029,463,802

Number of Initial Consideration Shares

5,397,451,305

Number of Subscription Shares

510,000,000

Number of Warrant Shares New Ordinary Shares issued on exercise of Warrants (0.25p)

830,800,000

Number of Fee Shares

75,000,000

Enlarged Share Capital

8,842,715,107

Gross Proceeds of the Subscription

£2,550,000

Expenses relating to the Subscription

£153,000

Net Proceeds of the Subscription receivable by the Company

£2,397,000

Transaction Costs

£1,081,319

Warrant Exercise Proceeds following exercise of Warrants (0.25p)

£2,077,000

Initial Consideration Shares as a percentage of the Enlarged Share Capital

61.0%

Subscription Shares as a percentage of the Enlarged Share Capital

5.8%

Warrant Shares as a percentage of the Enlarged Share Capital

9.4%

Fee Shares as a percentage of the Enlarged Share Capital

0.8%

Subscription Price

0.5 pence

Market capitalisation at the Subscription Price on Admission

£44,213,575.54

 

 

 

Appendices

 

The Directors

 

Brief biographical details of the members of the proposed board on Admission are set out below:

 

Nicholas Tulloch, Proposed Non-Executive Chairman, aged 49

 

Mr Tulloch has advised companies on the UK capital markets for over 20 years, working for several well-known investment banks and stockbrokers, including Cazenove, Arbuthnot, Cenkos and Cantor Fitzgerald. With a particular focus on oil and gas, Mr Tulloch has worked on several cross-border transactions in many parts of the world. In 2019 he became finance director and then subsequently CEO of Zoetic International plc transforming the company from its oil and gas roots to become the first vertically integrated CBD company to be listed in London. Mr Tulloch began his career as a solicitor with Gouldens and he holds a master's degree in law from Oxford University. Mr Tulloch stood for parliament in 2017.

 

Mr Tulloch will be appointed Non-executive Chairman with effect from Admission.

 

Christopher Theis, CEO, aged 62

 

Mr Theis is an experienced investment banker and entrepreneur. He has led number one rated City teams, including Smith New Court and Hoare Govett in the origination, structuring, flotation and placement of secondary market transactions of numerous successful companies. Chris has also founded a number of successful quoted and private businesses. Mr Theis holds an MBA from City University Business School.

 

John (Jack) Allardyce, Finance Director, aged 39

 

Mr Allardyce has over 15 years' experience in the energy sector, including 10 years as a leading equity research analyst with a number of UK investment banks. He began his career as a process engineer working on North Sea projects, before joining the leading research and consultancy house Wood Mackenzie, specialising in European upstream and unconventionals. Mr Allardyce's skillset spans global asset evaluation, financial forecasting, corporate advisory, M&A and equity capital markets. Mr Allardyce graduated from Heriot-Watt University with a degree in Chemical Engineering.

 

Martin Boughtwood, Proposed Chief Technical Officer, aged 67

 

Martin Boughtwood is the Founder and Managing Director of DG Innovate, an advanced research and development company focussing on the material science of energy storage and development of novel electric drive technologies. Martin Boughtwood is an inventor, with over 20 patents filed in the last 5 years. With his background in electronics, mechanical engineering and power management systems, and company leadership roles over 40 years, Martin Boughtwood focuses on the innovation of, sustainable, non-toxic solutions that leverage material property enhancements: improving energy efficiency for a host of applications across a plethora of potential end markets.

 

Martin Boughtwood is currently a director of DG Innovate. Martin Boughtwood will be appointed to the board conditional on Admission.

 

Patrick (Pat) Symonds, Proposed Independent Non-Executive Director, aged 68

 

Dr Symonds has had a 40+ year career in motorsport. He started his career designing championship winning cars for the lower formulae and then joined the fledgling Toleman F1 team working with Ayrton Senna. His subsequent partnerships with Michael Schumacher and Fernando Alonso produced 32 race wins, four Drivers' World Championships and three Constructors' World Championships. During this time he became Technical Director of the Benetton Formula One Team and latterly the Renault Formula One Team. After some years running his engineering consultancy, Neutrino Dynamics, he accepted an offer to become CTO at the Williams F1 team, a position he held until the end of the 2016 season. Dr Symonds is now Chief Technical Officer at F1 (Formula One Management) tasked with setting up a small technical group to assist the FIA in the formulation of future F1 and is involved in the transition of F1 to a low carbon economy. Dr Symonds is also a visiting professor at Cranfield University, a chartered engineer and a Fellow of both the Institution of Mechanical Engineers and the Royal Aeronautical Society.

 

Dr Symonds will be appointed to the board conditional on Admission.

 

Sir Stephen Dalton, Proposed Independent Non-Executive Director, aged 67

 

Sir Stephen Dalton served for nearly 40 years having joined the Royal Air Force in 1976 after graduating with an honours degree in Aeronautical Engineering from Bath University. Sir Stephen was appointed Head of the Royal Air Force in 2009 and retired from the Royal Air Force in 2013. He has worked with a number of major international companies advising them on the development of strategy and international engagement. He has also worked with a number of Company Boards helping them to improve their collective performance at Board level.

 

Sir Stephen Dalton was sworn into office as Lieutenant Governor of Jersey, in March 2017 at the start of his 5-year term of office and was President of The Royal Aeronautical Society for a one year fixed term position. He was appointed a Knight Commander of the Most Honourable Order of the Bath (KCB) in 2009 and advanced to Knight Grand Cross of the Order of the Bath (GCB) in 2012. In 2019, Her Majesty The Queen appointed him as Bath, King of Arms.

 

Sir Stephen Dalton will be appointed to the board conditional on Admission.

 

Andrew Boughtwood, Proposed Non-Executive Director, aged 63

 

Andrew Boughtwood is an experienced company director. For the last 17 years, he has been Managing Director of Megger Limited and overseas operations in over 30 countries. His is experienced across the electronic/electrical instrumentation field serving customers in communications, power contracting and utilities, industrial automation, power generation/ renewable energy, automotive, military and aerospace. Andrew Boughtwood is a graduate of Swansea University with a bachelor degree in computer technology.

 

Andrew Boughtwood is the brother of Martin Boughtwood and a shareholder of DG Innovate. Andrew Boughtwood will be appointed to the board conditional on Admission.

 

Trevor Gabriel, Proposed Non-Executive Director, aged 74

 

Mr Gabriel is managing partner of a real estate brokerage in Monaco, having previously been finance director of Camper & Nicholson International, the yacht brokerage firm . He is a chartered accountant and fellow of the ICAEW and spent 12 years with Jardine Matheson in finance and general management roles. He is currently non-executive director of TSX-V listed GlobalBlock Digital Asset Trading Limited and previously was a non-executive director of Kirkland Lake Gold Ltd while it was TSX listed and AIM quoted.

 

Mr Gabriel is currently a shareholder and director of DG Innovate. Mr Gabriel will be appointed to the board conditional on Admission.

 

Major Shareholders

 

So far as the Company is aware, the following persons, directly or indirectly, had/will have an interest in the Company's capital or Voting Rights which is notifiable under the Disclosure Guidance and Transparency Rules:

 

 

Last Practicable Date

Admission

Shareholder

Number of

Ordinary Shares

Percentage of issued

share capital

Number of Ordinary Shares

Percentage of Enlarged

Share Capital

Number of Options and Warrants

John Story

200,000,000(1)

9.9

485,000,000 (1)

5.5

180,000,000

Monecor (London) Limited

177,802,112

8.8

218,602,112

2.5

-

Spreadex Limited

121,086,246

6.0

165,436,246

1.9

44,350,000

Cantor Fitzgerald Europe

109,000,000

5.4

109,000,000

1.2

-

David Williams

110,000,000(2)

5.4

594,280,093 (3)

6.7

48,000,000

Richard & Charlotte Edwards

100,016,875

4.9

100,016,875

1.1

-

Christopher Theis

60,995,589

3.0

60,995,589

0.7

860,072,501(5)

Martin Boughtwood(4)

-

-

3,026,591,664

34.2

156,105,002(5)

Trevor Gabriel (6)

-

-

555,561,720

6.3

-

(1)

John Story's interest in these Ordinary Shares is held via a financial instrument issued by Argon Financial Limited.

(2)

Of these Ordinary Shares, 96,000,000 are registered in the name of Wentworth Limited, a company which is beneficially owned by David Williams and of which he is a director.

(3)

Of these Ordinary Shares, 192,000,000 will be registered in the name of Wentworth Limited, a company which is beneficially owned by David Williams and of which he is a director.

(4)

Martin Boughtwood's interest in Ordinary Shares includes 3,026,591,664 Ordinary Shares held by Deregallera Trust, a trust in which Denise Boughtwood (the spouse of Martin Boughtwood and a Connected Person) is the sole beneficiary. Martin Boughtwood's children Rebecca Louise Hainsworth and Lewis Raymond Boughtwood are the trustees of Deregallera Trust and are both Connected Persons.

(5)

The vesting of the following LTIP Options is performance based and measured over a three-year period to be determined by the Board: Chris Theis (78,052,501) and Martin Boughtwood (156,105,002).

(6)

Trevor Gabriel's interest in Ordinary Shares includes 555,561,720 Ordinary Shares held by Disruptech Ltd, a company in which Trevor Gabriel is the sole shareholder and a director.

 

The Concert Party

 

The Concert Party is made up of Martin Boughtwood, Trevor Gabriel and certain shareholders of DG Innovate. The members of Concert Party and their respective expected holdings following Admission are set out below. 

 

 

Last Practicable Date

 

Admission

Enlarged Share Capital

Admission

Partially Diluted Enlarged Share Capital

 

 

Interest in Existing Ordinary Shares

Interest in Options

Initial Consideration Shares to be issued

Interest in Enlarged Share Capital

Number of Concert Party Options

Entitlement to Deferred Consideration Shares

Interest in the Partially Diluted Enlarged Share Capital Assuming only Concert Party Options are exercised and the Deferred Consideration Shares are issued

 

Concert Party Member

No.

%

No.

No.

No.

%

No.

No.

No.

%

Martin Boughtwood(1)

-

-

-

3,026,591,664

3,026,591,664

34.2

156,105,002

502,208,943

3,684,905,609

37.1

Trevor Gabriel(2)

-

-

-

555,561,720

555,561,720

6.3

 

92,185,565

647,747,285

6.5

 

Michael Depper

-

-

-

252,528,054

252,528,054

2.9

 

41,902,529

294,430,583

3.0

 

Graham Weller

-

-

-

252,528,054

252,528,054

2.9

 

41,902,529

294,430,583

3.0

 

William Brogden

-

-

-

126,264,027

126,264,027

1.4

 

20,951,264

147,215,291

1.5

 

Andrew Boughtwood

-

-

-

75,758,416

75,758,416

0.9

 

12,570,758

88,329,174

0.9

 

Ross Hyett(3)

-

-

-

157,830,033

157,830,033

1.8

 

26,189,081

184,019,114

1.9

 

Rebecca Louise Hainsworth

-

-

-

6,060,674

6,060,674

0.1

4,947,453

1,005,661

12,013,788

0.1

Xin (Lucy) Liu

-

-

-

15,151,683

15,151,683

0.2

44,173,696

2,514,151

61,839,530

0.6

TOTAL

-

-

-

4,468,274,325

4,468,274,325

50.5

205,226,151

741,430,481

5,414,930,957

54.5

(1)

Martin Boughtwood's interest in Ordinary Shares includes 3,026,591,664 Ordinary Shares held by Deregallera Trust, a trust in which Denise Boughtwood (a connected person and the spouse of Martin Boughtwood) is the sole beneficiary. Martin Boughtwood's children Rebecca Louise Hainsworth and Lewis Raymond Boughtwood are the trustees of Deregallera Trust and are both connected persons of Martin Boughtwood.

 

(2)

Trevor Gabriel's interest in Ordinary Shares includes 555,561,720 Ordinary Shares held by Disruptech Ltd, a company in which Trevor Gabriel is the sole shareholder and a director.

 

(3)

Ross Hyett's interest in Ordinary Shares includes 157,830,033 Ordinary Shares held by Denton & Co Trustees Limited, a trustee of the pension trust in which Ross Hyett is the sole beneficiary.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PDIJIMJTMTMBBIT
Date   Source Headline
7th Apr 20227:00 amRNSUpdate on Acquisition
5th Apr 20227:00 amRNSInvestor Presentation
1st Apr 20222:45 pmRNSResult of General Meeting
14th Mar 20221:09 pmRNSPublication of Prospectus, Notice of GM, Fundraise
1st Feb 20227:00 amRNSProposed Transaction Update
31st Dec 20217:00 amRNSProposed Transaction Update
18th Nov 20217:00 amRNSAppointment of Joint Broker
26th Oct 20217:00 amRNSProposed Transaction Update
13th Oct 20216:02 pmRNSCorrection: Holding(s) in Company
13th Oct 20214:52 pmRNSHolding(s) in Company
11th Oct 20217:00 amRNSBlock listing Interim Review
29th Sep 20217:00 amRNSInterim Results for the six months to 30 June 2021
28th Sep 20212:45 pmRNSResult of AGM
22nd Sep 20212:41 pmRNSFurther secured loan provided to DG Innovate
9th Sep 20216:01 pmRNSHolding(s) in Company
2nd Sep 20217:00 amRNSNotice of AGM
18th Aug 202111:54 amRNSCorrection: Holding(s) in Company
18th Aug 20217:00 amRNSHolding(s) in Company
13th Aug 20217:45 amRNSProposed Acquisition of DG Innovate & Suspension
14th Jul 20215:23 pmRNSHolding(s) in Company
14th Jul 20212:39 pmRNSHolding(s) in Company
24th Jun 20217:00 amRNSFinal Results for the Year Ended 31 December 2020
16th Jun 20217:00 amRNSHolding(s) in Company
8th Jun 202111:49 amRNSHolding(s) in Company
7th Jun 202112:04 pmRNSHolding(s) in Company
9th Apr 202110:03 amRNSHolding(s) in Company
9th Apr 20217:00 amRNSBlock Listing
1st Apr 20215:02 pmRNSHolding(s) in Company
31st Mar 20219:55 amRNSTotal Voting Rights
24th Mar 20212:06 pmRNSDirector/PDMR Share Transaction
19th Mar 20218:53 amRNSHolding(s) in Company
12th Mar 20215:36 pmRNSAdmission of previously issued shares
12th Mar 202112:50 pmRNSPublication of Prospectus
8th Mar 202111:05 amRNSSecond Price Monitoring Extn
8th Mar 202111:00 amRNSPrice Monitoring Extension
1st Mar 20214:41 pmRNSSecond Price Monitoring Extn
1st Mar 20214:36 pmRNSPrice Monitoring Extension
26th Feb 20212:06 pmRNSSecond Price Monitoring Extn
26th Feb 20212:00 pmRNSPrice Monitoring Extension
26th Feb 20217:00 amRNSEquity Fundraise Update
19th Feb 20217:00 amRNS£3.5 million Equity Fundraise
15th Feb 20212:00 pmRNSTermination of DTU Acquisition
3rd Dec 20209:44 amRNSSubscription for £55,000 of Convertible Loan Stock
5th Nov 20207:00 amRNSFurther re the Acquisition of 75% of DT Ultravert
8th Oct 20209:55 amRNSOption Surrender and Issue of Replacement Options
5th Oct 20207:00 amRNSProposed sale of Kansas Land Leases and equipment
1st Oct 202011:41 amRNSFurther re the Acquisition of DT Ultravert
30th Sep 20207:00 amRNSBoard Changes & Acquisition of Deferred Shares
10th Sep 20201:30 pmRNSInterim Results for the six months to 30 June 2020
10th Sep 20201:15 pmRNSFinal Results for the Year Ended 31 December 2019

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.